Regulation of NKT cell localization in homeostasis and infection

Frontiers in Immunology

Volumn 6, Issue MAY, 2015, Pages

  Slauenwhite, Drew ^a   Johnston, Brent ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b Beatrice Hunter Cancer Research Institute   (Canada)

Author keywords

Chemokines; Cytokines; Homeostasis; Leukocyte homing; Natural killer T cells

Indexed keywords

HOMING RECEPTOR;

CELL HOMING; CELL MATURATION; CELLULAR DISTRIBUTION; CHLAMYDIASIS; CRYPTOCOCCOSIS; DENGUE; HEPATITIS; HOMEOSTASIS; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION; INFLUENZA; LYME DISEASE; MYCOBACTERIOSIS; NATURAL KILLER T CELL; NONHUMAN; REVIEW; SEPSIS; STREPTOCOCCUS INFECTION;

EID: 84934273845     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00255     Document Type: Review

References (268)

1. Cohen NR, Garg S, Brenner MB. Antigen presentation by CD1 lipids, T cells, and NKT cells in microbial immunity. Adv Immunol (2009) 102:1-94. doi:10.1016/S0065-2776(09)01201-2
2. Cullen R, Germanov E, Shimaoka T, Johnston B. Enhanced tumor metastasis in response to blockade of the chemokine receptor CXCR6 is overcome by NKT cell activation. J Immunol (2009) 183:5807-15. doi:10.4049/jimmunol.0803520
3. Coquet JM, Chakravarti S, Kyparissoudis K, McNab FW, Pitt LA, McKenzie BS, et al. Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1-NKT cell population. Proc Natl Acad Sci U S A (2008) 105:11287-92. doi:10.1073/pnas.0801631105
4. Gumperz JE, Miyake S, Yamamura T, Brenner MB. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med (2002) 195:625-36. doi:10.1084/jem.20011786
5. Kinjo Y, Kitano N, Kronenberg M. The role of invariant natural killer T cells in microbial immunity. J Infect Chemother (2013) 19:560-70. doi:10.1007/s10156-013-0638-1
6. Tupin E, Kinjo Y, Kronenberg M. The unique role of natural killer T cells in the response to microorganisms. Nat Rev Microbiol (2007) 5:405-17. doi:10.1038/nrmicro1657
7. Simoni Y, Diana J, Ghazarian L, Beaudoin L, Lehuen A. Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality? Clin Exp Immunol (2013) 171:8-19. doi:10.1111/j.1365-2249.2012.04625.x
8. Wu L, Van Kaer L. Natural killer T cells and autoimmune disease. Curr Mol Med (2009) 9:4-14. doi:10.2174/156652409787314534
9. Iwamura C, Nakayama T. Role of NKT cells in allergic asthma. Curr Opin Immunol (2010) 22:807-13. doi:10.1016/j.coi.2010.10.008
10. Meyer EH, DeKruyff RH, Umetsu DT. T cells and NKT cells in the pathogenesis of asthma. Annu Rev Med (2008) 59:281-92. doi:10.1146/annurev.med.59.061506.154139
11. Robertson FC, Berzofsky JA, Terabe M. NKT cell networks in the regulation of tumor immunity. Front Immunol (2014) 5:543. doi:10.3389/fimmu.2014.00543
12. Gapin L, Matsuda JL, Surh CD, Kronenberg M. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat Immunol (2001) 2:971-8. doi:10.1038/ni710
13. Godfrey DI, Stankovic S, Baxter AG. Raising the NKT cell family. Nat Immunol (2010) 11:197-206. doi:10.1038/ni.1841
14. Zhou D, Mattner J, Cantu C, Schrantz N, Yin N, Gao Y, et al. Lysosomal glycosphingolipid recognition by NKT cells. Science (2004) 306:1786-9. doi:10.1126/science.1103440
15. Fox LM, Cox DG, Lockridge JL, Wang X, Chen X, Scharf L, et al. Recognition of lyso-phospholipids by human natural killer T lymphocytes. PLoS Biol (2009) 7:e1000228. doi:10.1371/journal.pbio.1000228
16. Facciotti F, Ramanjaneyulu GS, Lepore M, Sansano S, Cavallari M, Kistowska M, et al. Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus. Nat Immunol (2012) 13:474-80. doi:10.1038/ni.2245
17. Brennan PJ, Tatituri RV, Brigl M, Kim EY, Tuli A, Sanderson JP, et al. Invariant natural killer T cells recognise lipid self antigen induced by microbial danger signals. Nat Immunol (2011) 12:1202-11. doi:10.1038/ni.2143
18. Kain L, Webb B, Anderson BL, Deng S, Holt M, Costanzo A, et al. The identification of the endogenous ligands of natural killer T cells reveals the presence of mammalian α-linked glycosylceramides. Immunity (2014) 41:543-54. doi:10.1016/j.immuni.2014.08.017
19. Christiansen D, Milland J, Mouhtouris E, Vaughan H, Pellicci DG, McConville MJ, et al. Humans lack iGb3 due to the absence of functional iGb3-synthase: implications for NKT cell development and transplantation. PLoS Biol (2008) 6:e172. doi:10.1371/journal.pbio.0060172
20. Brennan PJ, Tatituri RV, Heiss C, Watts GF, Hsu FF, Veerapen N, et al. Activation of iNKT cells by a distinct constituent of the endogenous glucosylceramide fraction. Proc Natl Acad Sci U S A (2014) 111:13433-8. doi:10.1073/pnas.1415357111
21. Lantz O, Bendelac A. An invariant T cell receptor a chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8-T cells in mice and humans. J Exp Med (1994) 180:1097-106. doi:10.1084/jem.180.3.1097
22. Porcelli S, Yockey CE, Brenner MB, Balk SP. Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8-α/β T cells demonstrates preferential use of several Vβ genes and an invariant TCR a chain. J Exp Med (1993) 178:1-16. doi:10.1084/jem.178.1.1
23. Benlagha K, Weiss A, Beavis A, Teyton L, Bendelac A. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J Exp Med (2000) 191:1895-903. doi:10.1084/jem.191.11.1895
24. Matsuda JL, Naidenko O, Gapin L, Nakayama T, Taniguchi M, Wang CR, et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med (2000) 192:741-54. doi:10.1084/jem.192.5.741
25. a14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection. Eur J Immunol (2003) 33:3322-30. doi:10.1002/eji.200324254
26. Ho LP, Denney L, Luhn K, Teoh D, Clelland C, McMichael AJ. Activation of invariant NKT cells enhances the innate immune response and improves the disease course in influenza A virus infection. Eur J Immunol (2008) 38:1913-22. doi:10.1002/eji.200738017
27. Bilenki L, Yang J, Fan Y, Wang S, Yang X. Natural killer T cells contribute to airway eosinophilic inflammation induced by ragweed through enhanced IL-4 and eotaxin production. Eur J Immunol (2004) 34:345-54. doi:10.1002/eji.200324303
28. Shimizu K, Goto A, Fukui M, Taniguchi M, Fujii S. Tumor cells loaded with α-galactosylceramide induce innate NKT and NK cell-dependent resistance to tumor implantation in mice. J Immunol (2007) 178:2853-61. doi:10.4049/jimmunol.178.5.2853
29. Arrenberg P, Halder R, Dai Y, Maricic I, Kumar V. Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a ß-linked self-glycolipid. Proc Natl Acad Sci U S A (2010) 107:10984-9. doi:10.1073/pnas.1000576107
30. Park SH, Weiss A, Benlagha K, Kyin T, Teyton L, Bendelac A. The mouse CD1d-restricted repertoire is dominated by a few autoreactive T cell receptor families. J Exp Med (2001) 193:893-904. doi:10.1084/jem.193.8.893
31. Patel O, Pellicci DG, Gras S, Sandoval-Romero ML, Uldrich AP, Mallevaey T, et al. Recognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptor. Nat Immunol (2012) 13:857-63. doi:10.1038/ni.2372
32. Terabe M, Swann J, Ambrosino E, Sinha P, Takaku S, Hayakawa Y, et al. A nonclassical non-Vα14Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance. J Exp Med (2005) 202:1627-33. doi:10.1084/jem.20051381
33. Ambrosino E, Terabe M, Halder RC, Peng J, Takaku S, Miyake S, et al. Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis. J Immunol (2007) 179:5126-36. doi:10.4049/jimmunol.179.8.5126
34. Renukaradhya GJ, Khan MA, Vieira M, Du W, Gervay-Hague J, Brutkiewicz RR. Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma. Blood (2008) 111:5637-45. doi:10.1182/blood-2007-05-092866
35. Girardi E, Maricic I, Wang J, Mac TT, Iyer P, Kumar V, et al. Type II natural killer T cells use features of both innate-like and conventional T cells to recognize sulfatide self antigens. Nat Immunol (2012) 13:851-6. doi:10.1038/ni.2371
36. Zhang G, Nie H, Yang J, Ding X, Huang Y, Yu H, et al. Sulfatide-activated type II NKT cells prevent allergic airway inflammation by inhibiting type I NKT cell function in a mouse model of asthma. Am J Physiol Lung Cell Mol Physiol (2011) 301:975-84. doi:10.1152/ajplung.00114.2011
37. Halder RC, Aguilera C, Maricic I, Kumar V. Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease. J Clin Invest (2007) 117:2302-12. doi:10.1172/JCI31602.2302
38. Arrenberg P, Maricic I, Kumar V. Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice. Gastroenterology (2011) 140:646-55. doi:10.1053/j.gastro.2010.10.003
39. Jahng A, Maricic I, Aguilera C, Cardell S, Halder RC, Kumar V. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J Exp Med (2004) 199:947-57. doi:10.1084/jem.20031389
40. Kwiecinski J, Rhost S, Löfbom L, Blomqvist M, Månsson JE, Cardell SL, et al. Sulfatide attenuates experimental Staphylococcus aureus sepsis through a CD1d-dependent pathway. Infect Immun (2013) 81:1114-20. doi:10.1128/IAI.01334-12
41. Fuss IJ, Heller F, Boirivant M, Leon F, Yoshida M, Fichtner-Feigl S, et al. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest (2004) 113:1490-7. doi:10.1172/JCI19836
42. Liao CM, Zimmer MI, Shanmuganad S, Yu HT, Cardell SL, Wang CR. Dysregulation of CD1d-restricted type II natural killer T cells leads to spontaneous development of colitis in mice. Gastroenterology (2012) 142:326-34. doi:10.1053/j.gastro.2011.10.030
43. Exley MA, Tahir SM, Cheng O, Shaulov A, Joyce R, Avigan D, et al. A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses. J Immunol (2001) 167:5531-4. doi:10.4049/jimmunol.167.10.5531
44. Montoya CJ, Jie HB, Al-Harthi L, Mulder C, Patino PJ, Rugeles MT, et al. Activation of plasmacytoid dendritic cells with TLR9 agonists initiates invariant NKT cell-mediated cross-talk with myeloid dendritic cells. J Immunol (2006) 177:1028-39. doi:10.4049/jimmunol.177.2.1028
45. Coquet JM, Kyparissoudis K, Pellicci DG, Besra G, Berzins SP, Smyth MJ, et al. IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J Immunol (2007) 178:2827-34. doi:10.4049/jimmunol.178.5.2827
46. Brigl M, Tatituri R, Watts GF, Bhowruth V, Leadbetter EA, Barton N, et al. Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection. J Exp Med (2011) 208:1163-77. doi:10.1084/jem.20102555
47. Wong CH, Jenne CN, Lee WY, Léger C, Kubes P. Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science (2011) 334:101-5. doi:10.1126/science.1210301
48. + NKT cells to initiate contact sensitivity in vivo. J Immunol (2005) 175:6390-401. doi:10.4049/jimmunol.175.10.6390
49. Grela F, Aumeunier A, Bardel E, Van LP, Bourgeois E, Vanoirbeek J, et al. The TLR7 agonist R848 alleviates allergic inflammation by targeting invariant NKT cells to produce IFN-γ. J Immunol (2011) 186:284-90. doi:10.4049/jimmunol.1001348
50. Kim JH, Kim HS, Kim HY, Oh SJ, Chung DH. Direct engagement of TLR4 in invariant NKT cells regulates immune diseases by differential IL-4 and IFN-γ production in mice. PLoS One (2012) 7:e45348. doi:10.1371/journal.pone.0045348
51. Paget C, Ivanov S, Fontaine J, Renneson J, Blanc F, Pichavant M, et al. Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages. J Biol Chem (2012) 287:8816-29. doi:10.1074/jbc. M111.304758
52. Brennan PJ, Brigl M, Brenner MB. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat Rev Immunol (2013) 13:101-17. doi:10.1038/nri3369
53. Constantinides MG, Bendelac A. Transcriptional regulation of the NKT cell lineage. Curr Opin Immunol (2013) 25:161-7. doi:10.1016/j.coi.2013.01.003
54. Doisne JM, Becourt C, Amniai L, Duarte N, Le Luduec JB, Eberl G, et al. Skin and peripheral lymph node invariant NKT cells are mainly retinoic acid receptor-related orphan receptor γt+ and respond preferentially under inflammatory conditions. J Immunol (2009) 183:2142-9. doi:10.4049/jimmunol.0901059
55. Lee YJ, Holzapfel KL, Zhu J, Jameson SC, Hogquist KA. Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat Immunol (2013) 14:1146-54. doi:10.1038/ni.2731
56. Michel ML, Keller AC, Paget C, Fujio M, Trottein F, Savage PB, et al. Identification of an IL-17-producing NK1.1neg iNKT cell population involved in airway neutrophilia. J Exp Med (2007) 204:995-1001. doi:10.1084/jem.20061551
57. Sag D, Krause P, Hedrick CC, Kronenberg M, Wingender G. IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset. J Clin Invest (2014) 124:3725-40. doi:10.1172/JCI72308
58. Watarai H, Sekine-Kondo E, Shigeura T, Motomura Y, Yasuda T, Satoh R, et al. Development and function of invariant natural killer T cells producing TH2-and TH17-cytokines. PLoS Biol (2012) 10:e1001255. doi:10.1371/journal.pbio.1001255
59. Lynch L, Michelet X, Zhang S, Brennan PJ, Moseman A, Lester C, et al. Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of Treg cells and macrophages in adipose tissue. Nat Immunol (2015) 16:85-96. doi:10.1038/ni.3047
60. Carnaud C, Lee D, Donnars O, Park S, Beavis A, Koezuka Y, et al. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol (1999) 163:4647-50.
61. Fujii S, Shimizu K, Smith C, Bonifaz L, Steinman RM. Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J Exp Med (2003) 198:267-79. doi:10.1084/jem.20030324
62. Münz C, Steinman RM, Fujii S. Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J Exp Med (2005) 202:203-7. doi:10.1084/jem.20050810
63. Dondji B, Deak E, Goldsmith-Pestana K, Perez-Jimenez E, Esteban M, Miyake S, et al. Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection against Leishmania. Eur J Immunol (2008) 38:706-19. doi:10.1002/eji.200737660
64. Godfrey DI, Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest (2004) 114:1379-88. doi:10.1172/JCI23594
65. King IL, Fortier A, Tighe M, Dibble J, Watts GF, Veerapen N, et al. Invariant natural killer T cells direct B cell responses to cognate lipid antigen in an IL-21-dependent manner. Nat Immunol (2011) 13:44-50. doi:10.1038/ni.2172
66. McNab FW, Berzins SP, Pellicci DG, Kyparissoudis K, Field K, Smyth MJ, et al. The influence of CD1d in postselection NKT cell maturation and homeostasis. J Immunol (2005) 175:3762-8. doi:10.4049/jimmunol.175.6.3762
67. a14i NKT cells. Nat Immunol (2002) 3:966-74. doi:10.1038/ni837
68. Wei DG, Lee H, Park SH, Beaudoin L, Teyton L, Lehuen A, et al. Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes. J Exp Med (2005) 202:239-48. doi:10.1084/jem.20050413
69. Ranson T, Vosshenrich CA, Corcuff E, Richard O, Laloux V, Lehuen A, et al. IL-15 availability conditions homeostasis of peripheral natural killer T cells. Proc Natl Acad Sci U S A (2003) 100:2663-8. doi:10.1073/pnas.0535482100
70. Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, Embers M, et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med (2000) 191:771-80. doi:10.1084/jem.191.5.771
71. Akbari O, Stock P, Meyer EH, Freeman GJ, Sharpe AH, Umetsu DT, et al. ICOS/ICOSL interaction is required for CD4+ invariant NKT cell function and homeostatic survival. J Immunol (2008) 180:5448-56. doi:10.4049/jimmunol.180.8.5448
72. a18 natural T lymphocytes require signal processing by protein kinase C θ and NF-κB. J Immunol (2004) 172:4667-71. doi:10.4049/jimmunol.172.8.4667
73. a14i NKT cells. Immunity (2004) 20:477-94. doi:10.1016/S1074-7613(04)00076-7
74. a14i NKT cells. Blood (2006) 107:2797-805. doi:10.1182/blood-2005-08-3103
75. + natural killer T cell development depends on c-Myc. Proc Natl Acad Sci U S A (2009) 106:8641-6. doi:10.1073/pnas.0812255106
76. a14i NKT cell development. J Immunol (2009) 182:4641-8. doi:10.4049/jimmunol.0803394
77. Prevot N, Pyaram K, Bischoff E, Sen JM, Powell JD, Chang CH. Mammalian target of rapamycin complex 2 regulates invariant NKT cell development and function independent of promyelocytic leukemia zinc-finger. J Immunol (2015) 194:223-30. doi:10.4049/jimmunol.1401985
78. Lazarevic V, Zullo AJ, Schweitzer MN, Staton TL, Gallo EM, Crabtree GR, et al. The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells. Nat Immunol (2009) 10:306-13. doi:10.1038/ni.1696
79. Monticelli LA, Yang Y, Knell J, D'Cruz LM, Cannarile MA, Engel I, et al. Transcriptional regulator Id2 controls survival of hepatic NKT cells. Proc Natl Acad Sci U S A (2009) 106:19461-6. doi:10.1073/pnas.0908249106
80. Stanic AK, Bezbradica JS, Park JJ, Matsuki N, Mora AL, Van Kaer L, et al. NF-κB controls cell fate specification, survival, and molecular differentiation of immunoregulatory natural T lymphocytes. J Immunol (2004) 172:2265-73. doi:10.4049/jimmunol.172.4.2265
81. Gordy LE, Bezbradica JS, Flyak AI, Spencer CT, Dunkle A, Sun J, et al. IL-15 regulates homeostasis and terminal maturation of NKT cells. J Immunol (2011) 187:6335-45. doi:10.4049/jimmunol.1003965
82. Ohteki T, Ho S, Suzuki H, Mak TW, Ohashi PS. Role for IL-15/IL-15 receptor β-chain in natural killer 1.1+ T cell receptor αβ+ cell development. J Immunol (1997) 159:5931-5.
83. Boesteanu A, De Silva AD, Nakajima H, Leonard WJ, Peschon JJ, Joyce S. Distinct roles for signals relayed through the common cytokine receptor α chain and interleukin 7 receptor α chain in natural T cell development. J Exp Med (1997) 186:331-6. doi:10.1084/jem.186.2.331
84. Lodolce JP, Boone DL, Chai S, Swain RE, Dassopoulos T, Trettin S, et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity (1998) 9:669-76. doi:10.1016/S1074-7613(00)80664-0
85. Chang CL, Lai YG, Hou MS, Huang PL, Liao NS. IL-15Ra of radiation-resistant cells is necessary and sufficient for thymic invariant NKT cell survival and functional maturation. J Immunol (2011) 187:1235-42. doi:10.4049/jimmunol.1100270
86. Matloubian M, David A, Engel S, Ryan JE, Cyster JG. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol (2000) 1:298-304. doi:10.1038/79738
87. Kim CH, Johnston B, Butcher EC. Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among Vα24+Vβ11+ NKT cell subsets with distinct cytokine-producing capacity. Blood (2002) 100:11-6. doi:10.1182/blood-2001-12-0196
88. Johnston B, Kim CH, Soler D, Emoto M, Butcher EC. Differential chemokine responses and homing patterns of murine TCR αβ NKT cell subsets. J Immunol (2003) 171:2960-9. doi:10.4049/jimmunol.171.6.2960
89. Thomas SY, Hou R, Boyson JE, Means TK, Hess C, Olson DP, et al. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J Immunol (2003) 171:2571-80. doi:10.4049/jimmunol.171.5.2571
90. Geissmann F, Cameron TO, Sidobre S, Manlongat N, Kronenberg M, Briskin MJ, et al. Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol (2005) 3:e113. doi:10.1371/journal.pbio.0030113
91. Germanov E, Veinotte L, Cullen R, Chamberlain E, Butcher EC, Johnston B. Critical role for the chemokine receptor CXCR6 in homeostasis and activation of CD1d-restricted NKT cells. J Immunol (2008) 181:81-91. doi:10.4049/jimmunol.181.1.81
92. Shimaoka T, Seino K, Kume N, Minami M, Nishime C, Suematsu M, et al. Critical role for CXC chemokine ligand 16 (SR-PSOX) in Th1 response mediated by NKT cells. J Immunol (2007) 179:8172-9. doi:10.4049/jimmunol.179.12.8172
93. Ajuebor MN, Aspinall AI, Zhou F, Le T, Yang Y, Urbanski SJ, et al. Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells. J Immunol (2005) 174:8027-37. doi:10.4049/jimmunol.174.12.8027
94. Murooka TT, Wong MM, Rahbar R, Majchrzak-Kita B, Proudfoot AE, Fish EN. CCL5-CCR5-mediated apoptosis in T cells: requirement for glycosaminoglycan binding and CCL5 aggregation. J Biol Chem (2006) 281:25184-94. doi:10.1074/jbc. M603912200
95. Algeciras-Schimnich A, Vlahakis SR, Villasis-Keever A, Gomez T, Heppelmann CJ, Bou G, et al. CCR5 mediates Fas-and caspase-8 dependent apoptosis of both uninfected and HIV infected primary human CD4 T cells. AIDS (2002) 16:1467-78. doi:10.1097/00002030-200207260-00003
96. Olszak T, An D, Zeissig S, Vera MP, Richter J, Franke A, et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science (2012) 336:489-93. doi:10.1126/science.1219328
97. Wei B, Wingender G, Fujiwara D, Chen DY, McPherson M, Brewer S, et al. Commensal microbiota and CD8+ T cells shape the formation of invariant NKT cells. J Immunol (2010) 184:1218-26. doi:10.4049/jimmunol.0902620
98. Wingender G, Stepniak D, Krebs P, Lin L, McBride S, Wei B, et al. Intestinal microbes affect phenotypes and functions of invariant natural killer T cells in mice. Gastroenterology (2012) 143:418-28. doi:10.1053/j.gastro.2012.04.017
99. Huttenhower C, Gevers D, Knight R, Abubucker S, Badger JH, Chinwalla AT, et al. Structure, function and diversity of the healthy human microbiome. Nature (2012) 486:207-14. doi:10.1038/nature11234
100. Wieland Brown LC, Penaranda C, Kashyap PC, Williams BB, Clardy J, Kronenberg M, et al. Production of α-galactosylceramide by a prominent member of the human gut microbiota. PLoS Biol (2013) 11:e1001610. doi:10.1371/journal.pbio.1001610
101. An D, Oh SF, Olszak T, Neves JF, Avci FY, Erturk-Hasdemir D, et al. Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells. Cell (2014) 156:123-33. doi:10.1016/j.cell.2013.11.042
102. Nieuwenhuis EE, Matsumoto T, Lindenbergh D, Willemsen R, Kaser A, Simons-Oosterhuis Y, et al. CD1d-dependent regulation of bacterial colonization in the intestine of mice. J Clin Invest (2009) 119:1241-50. doi:10.1172/JCI36509DS1
103. Olszak T, Neves JF, Dowds CM, Baker K, Glickman J, Davidson NO, et al. Protective mucosal immunity mediated by epithelial CD1d and IL-10. Nature (2014) 509:497-502. doi:10.1038/nature13150
104. Pellicci DG, Hammond KJ, Uldrich AP, Baxter AG, Smyth MJ, Godfrey DI. A natural killer T (NKT) cell developmental pathway involving a thymus-dependent NK1.1-CD4+ CD1d-dependent precursor stage. J Exp Med (2002) 195:835-44. doi:10.1084/jem.20011544
105. Eberl G, Lees R, Smiley ST, Taniguchi M, Grusby MJ, MacDonald HR. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J Immunol (1999) 162:6410-9.
106. Hammond KJ, Pellicci DG, Poulton LD, Naidenko O, Scalzo AA, Baxter AG, et al. CD1d-restricted NKT cells: an interstrain comparison. J Immunol (2001) 167:1164-73. doi:10.4049/jimmunol.167.3.1164
107. Laloux V, Beaudoin L, Ronet C, Lehuen A. Phenotypic and functional differences between NKT cells colonizing splanchnic and peripheral lymph nodes. J Immunol (2002) 168:3251-8. doi:10.4049/jimmunol.168.7.3251
108. Scanlon ST, Thomas SY, Ferreira CM, Bai L, Krausz T, Savage PB, et al. Airborne lipid antigens mobilize resident intravascular NKT cells to induce allergic airway inflammation. J Exp Med (2011) 208:2113-24. doi:10.1084/jem.20110522
109. a18 CD1d-restricted) NKT cells suppress graft-versus-host disease by producing IFN-γ and IL-4. J Immunol (2007) 179:6579-87. doi:10.4049/jimmunol.179.10.6579
110. Thomas SY, Scanlon ST, Griewank KG, Constantinides MG, Savage AK, Barr KA, et al. PLZF induces an intravascular surveillance program mediated by long-lived LFA-1-ICAM-1 interactions. J Exp Med (2011) 208:1179-88. doi:10.1084/jem.20102630
111. a24) natural killer T cells in the early human fetal thymus is regulated by IL-7. Proc Natl Acad Sci U S A (2004) 101:7058-63. doi:10.1073/pnas.0305986101
112. Berzins SP, Cochrane AD, Pellicci DG, Smyth MJ, Godfrey DI. Limited correlation between human thymus and blood NKT cell content revealed by an ontogeny study of paired tissue samples. Eur J Immunol (2005) 35:1399-407. doi:10.1002/eji.200425958
113. Loh L, Ivarsson MA, Michaëlsson J, Sandberg JK, Nixon DF. Invariant natural killer T cells developing in the human fetus accumulate and mature in the small intestine. Mucosal Immunol (2014) 7:1233-43. doi:10.1038/mi.2014.13
114. Kita H, Naidenko O, Kronenberg M, Ansari AA, Rogers P, He X, et al. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology (2002) 123:1031-43. doi:10.1053/gast.2002.36020
115. Kenna T, Golden-Mason L, Porcelli SA, Koezuka Y, Hegarty JE, O'Farrelly C, et al. NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells. J Immunol (2003) 171:1775-9. doi:10.4049/jimmunol.171.4.1775
116. a24 natural killer T cells. J Exp Med (2002) 195:637-41. doi:10.1084/jem.20011908
117. Chan AC, Serwecinska L, Cochrane A, Harrison LC, Godfrey DI, Berzins SP. Immune characterization of an individual with an exceptionally high natural killer T cell frequency and her immediate family. Clin Exp Immunol (2009) 156:238-45. doi:10.1111/j.1365-2249.2009.03888.x
118. Lee PT, Putnam A, Benlagha K, Teyton L, Gottlieb PA, Bendelac A. Testing the NKT cell hypothesis of human IDDM pathogenesis. J Clin Invest (2002) 110:793-800. doi:10.1172/JCI15832
119. Crough T, Purdie DM, Okai M, Maksoud A, Nieda M, Nicol AJ. Modulation of human Vα24+Vβ11+ NKT cells by age, malignancy and conventional anticancer therapies. Br J Cancer (2004) 91:1880-6. doi:10.1038/sj.bjc.6602218
120. a24 NKT cells in primary lung cancer patients. Int J Cancer (2002) 102:159-65. doi:10.1002/ijc.10678
121. Kawano T, Nakayama T, Kamada N, Kaneko Y, Harada M, Ogura N, et al. Antitumor cytotoxicity mediated by ligand-activated human Vα24 NKT cells. Cancer Res (1999) 59:5102-5.
122. Tahir SM, Cheng O, Shaulov A, Koezuka Y, Bubley GJ, Wilson SB, et al. Loss of IFN-α production by invariant NK T cells in advanced cancer. J Immunol (2001) 167:4046-50. doi:10.4049/jimmunol.167.7.4046
123. + NK T cells activated by α-galactosylceramide-pulsed monocyte-derived dendritic cells. J Immunol (2002) 168:3140-4. doi:10.4049/jimmunol.168.7.3140
124. Chan AC, Leeansyah E, Cochrane A, d'Udekem d'Acoz Y, Mittag D, Harrison LC, et al. Ex-vivo analysis of human natural killer T cells demonstrates heterogeneity between tissues and within established CD4+ and CD4-subsets. Clin Exp Immunol (2013) 172:129-37. doi:10.1111/cei.12045
125. Emoto M, Zerrahn J, Miyamoto M, Pérarnau B, Kaufmann SH. Phenotypic characterization of CD8+NKT cells. Eur J Immunol (2000) 30:2300-11. doi:10.1002/1521-4141(2000)30:8
126. Akbari O, Stock P, Meyer E, Kronenberg M, Sidobre S, Nakayama T, et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med (2003) 9:582-8. doi:10.1038/nm851
127. Akbari O, Faul JL, Hoyte EG, Berry GJ, Wahlstrom J, Kronenberg M, et al. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N Engl J Med (2006) 354:1117-29. doi:10.1056/NEJMoa053614
128. Crowe NY, Coquet JM, Berzins SP, Kyparissoudis K, Keating R, Pellicci DG, et al. Differential antitumor immunity mediated by NKT cell subsets in vivo. J Exp Med (2005) 202:1279-88. doi:10.1084/jem.20050953
129. Chang PP, Barral P, Fitch J, Pratama A, Ma CS, Kallies A, et al. Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses. Nat Immunol (2011) 13:35-43. doi:10.1038/ni.2166
130. Johnston B, Butcher EC. Chemokines in rapid leukocyte adhesion triggering and migration. Semin Immunol (2002) 14:83-92. doi:10.1006/smim.2001.0345
131. Stein JV, Rot A, Luo Y, Narasimhaswamy M, Nakano H, Gunn MD, et al. The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J Exp Med (2000) 191:61-76. doi:10.1084/jem.191.1.61
132. Warnock RA, Askari S, Butcher EC, Andrian UH. Molecular mechanisms of lymphocyte homing to peripheral lymph nodes. J Exp Med (1998) 187:205-16. doi:10.1084/jem.187.2.205
133. Hamann A, Andrew DP, Jablonski-Westrich D, Hoizmann B, Butcher EC. Role of a4-integrins in lymphocyte homing to mucosal tissues in vivo. J Immunol (1994) 152:3282-93.
134. Kunkel EJ, Campbell JJ, Haraldsen G, Pan J, Boisvert J, Roberts AI, et al. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J Exp Med (2000) 192:761-8. doi:10.1084/jem.192.5.761
135. Soler D, Humphreys TL, Spinola SM, Campbell JJ. CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking. Blood (2003) 101:1677-83. doi:10.1182/blood-2002-07-2348
136. Kunkel EJ, Butcher EC. Chemokines and the tissue-specific migration of lymphocytes. Immunity (2002) 16:1-4. doi:10.1016/S1074-7613(01)00261-8
137. Kim CH, Rott L, Kunkel EJ, Genovese MC, Andrew DP, Wu L, et al. Rules of chemokine receptor association with T cell polarization in vivo. J Clin Invest (2001) 108:1331-9. doi:10.1172/JCI13543
138. a24-invariant NKT cells: cytokine responses and chemokine receptor expression. Trends Immunol (2002) 23:516-9. doi:10.1016/S1471-4906(02)02323-2
139. Schaerli P, Ebert L, Willimann K, Blaser A, Roos RS, Loetscher P, et al. A skin-selective homing mechanism for human immune surveillance T cells. J Exp Med (2004) 199:1265-75. doi:10.1084/jem.20032177
140. Harner S, Noessner E, Nadas K, Leumann-Runge A, Schiemann M, Faber FL, et al. Cord blood Vα24-Vβ11 natural killer T cells display a Th2-chemokine receptor profile and cytokine responses. PLoS One (2011) 6:e15714. doi:10.1371/journal.pone.0015714
141. Rolf J, Berntman E, Stenström M, Smith EM, Månsson R, Stenstad H, et al. Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets. Mol Immunol (2008) 45:2607-20. doi:10.1016/j.molimm.2007.12.022
142. Lin H, Nieda M, Hutton JF, Rozenkov V, Nicol AJ. Comparative gene expression analysis of NKT cell subpopulations. J Leukoc Biol (2006) 80:164-73. doi:10.1189/jlb.0705421.0741-5400/06/0080-164
143. Kim CH, Pelus LM, White JR, Broxmeyer HE. Differential chemotactic behavior of developing T cells in response to thymic chemokines. Blood (1998) 91:4434-43.
144. Campbell JJ, Pan J, Butcher EC. Cutting edge: developmental switches in chemokine responses during T cell maturation. J Immunol (1999) 163:2353-7.
145. Bleul CC, Boehm T. Chemokines define distinct microenvironments in the developing thymus. Eur J Immunol (2000) 30:3371-9. doi:10.1002/1521-4141(2000012)30:12
146. + thymocytes and γδTCR+ thymocytes preferentially respond to CCL25. J Immunol (2002) 168:134-42. doi:10.4049/jimmunol.168.1.134
147. + cells. J Immunol (2000) 164:2412-8. doi:10.4049/jimmunol.164.5.2412
148. Cowan JE, McCarthy NI, Parnell SM, White AJ, Bacon A, Serge A, et al. Differential requirement for CCR4 and CCR7 during the development of innate and adaptive αβT cells in the adult thymus. J Immunol (2014) 193:1204-12. doi:10.4049/jimmunol.1400993
149. White AJ, Jenkinson WE, Cowan JE, Parnell SM, Bacon A, Jones ND, et al. An essential role for medullary thymic epithelial cells during the intrathymic development of invariant NKT cells. J Immunol (2014) 192:2659-66. doi:10.4049/jimmunol.1303057
150. Berzins SP, McNab FW, Jones CM, Smyth MJ, Godfrey DI. Long-term retention of mature NK1.1+ NKT cells in the thymus. J Immunol (2006) 176:4059-65. doi:10.4049/jimmunol.176.7.4059
151. Drennan MB, Franki AS, Dewint P, Van Beneden K, Seeuws S, van de Pavert SA, et al. Cutting edge: the chemokine receptor CXCR3 retains invariant NK T cells in the thymus. J Immunol (2009) 183:2213-6. doi:10.4049/jimmunol.0901213
152. Berzins SP, Uldrich AP, Pellicci DG, McNab FW, Hayakawa Y, Smyth MJ, et al. Parallels and distinctions between T and NKT cell development in the thymus. Immunol Cell Biol (2004) 82:269-75. doi:10.1111/j.1440-1711.2004.01256.x
153. Wilbanks A, Zondlo SC, Murphy K, Mak S, Soler D, Langdon P, et al. Expression cloning of the STRL33/BONZO/TYMSTR ligand reveals elements of CC, CXC, and CX3C chemokines. J Immunol (2001) 166:5145-54. doi:10.4049/jimmunol.166.8.5145
154. Kim CH, Kunkel EJ, Boisvert J, Johnston B, Campbell JJ, Genovese MC, et al. Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. J Clin Invest (2001) 107:595-601. doi:10.1172/JCI11902
155. Lim HW, Lee J, Hillsamer P, Kim CH. Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells. J Immunol (2008) 180:122-9. doi:10.4049/jimmunol.180.1.122
156. Slauenwhite D, Gebremeskel S, Doucette CD, Hoskin DW, Johnston B. Regulation of cytokine polarization and T cell recruitment to inflamed paws in mouse collagen-induced arthritis by the chemokine receptor CXCR6. Arthritis Rheumatol (2014) 66:3001-12. doi:10.1002/art.38816
157. Emoto M, Mittrücker HW, Schmits R, Mak TW, Kaufmann SH. Critical role of leukocyte function-associated antigen-1 in liver accumulation of CD4+NKT cells. J Immunol (1999) 162:5094-8.
158. Ohteki T, Maki C, Koyasu S, Mak TW, Ohashi PS. Cutting edge: LFA-1 is required for liver NK1.1+ TCR αβ+ cell development: evidence that liver NK1.1+ TCR αβ+ cells originate from multiple pathways. J Immunol (1999) 162:3753-6.
159. Semmling V, Lukacs-Kornek V, Thaiss CA, Quast T, Hochheiser K, Panzer U, et al. Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs. Nat Immunol (2010) 11:313-20. doi:10.1038/ni.1848
160. Meyer EH, Wurbel MA, Staton TL, Pichavant M, Kan MJ, Savage PB, et al. iNKT cells require CCR4 to localize to the airways and to induce airway hyperreactivity. J Immunol (2007) 179:4661-71. doi:10.4049/jimmunol.179.7.4661
161. Kastenmüller W, Torabi-Parizi P, Subramanian N, Lämmermann T, Germain RN. A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell (2012) 150:1235-48. doi:10.1016/j.cell.2012.07.021
162. + macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes. Nat Immunol (2010) 11:303-12. doi:10.1038/ni.1853
163. Rachitskaya AV, Hansen AM, Horai R, Li Z, Villasmil R, Luger D, et al. Cutting edge: NKT cells constitutively express IL-23 receptor and RORγt and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J Immunol (2008) 180:5167-71. doi:10.4049/jimmunol.180.8.5167
164. Michel M, Mendes-da-Cruz D, Keller AC, Lochner M, Schneider E, Dy M, et al. Critical role of ROR-γt in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. Proc Natl Acad Sci U S A (2008) 105:19845-50. doi:10.1073/pnas.0806472105
165. Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, Sugimoto N, et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med (2007) 204:2803-12. doi:10.1084/jem.20071397
166. Katchar K, Kelly CP, Keates S, O'Brien MJ, Keates AC. MIP-3a neutralizing monoclonal antibody protects against TNBS-induced colonic injury and inflammation in mice. Am J Physiol Gastrointest Liver Physiol (2007) 292:G1263-71. doi:10.1152/ajpgi.00409.2006
167. Moreira-Teixeira L, Resende M, Coffre M, Devergne O, Herbeuval JP, Hermine O, et al. Proinflammatory environment dictates the IL-17-producing capacity of human invariant NKT cells. J Immunol (2011) 186:5758-65. doi:10.4049/jimmunol.1003043
168. Monteiro M, Almeida CF, Agua-Doce A, Graca L. Induced IL-17-producing invariant NKT cells require activation in presence of TGF-β and IL-1β. J Immunol (2013) 190:805-11. doi:10.4049/jimmunol.1201010
169. Forster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell (1996) 87:1037-47. doi:10.1016/S0092-8674(00)81798-5
170. Reif K, Ekland EH, Ohl L, Nakano H, Lipp M, Forster R, et al. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature (2002) 416:94-9. doi:10.1038/416094a
171. Campbell DJ, Kim CH, Butcher EC. Separable effector T cell populations specialized for B cell help or tissue inflammation. Nat Immunol (2001) 2:876-81. doi:10.1038/ni0901-876
172. Kim CH, Rott LS, Clark-Lewis I, Campbell DJ, Wu L, Butcher EC. Subspecialization of CXCR5+ T cells: B helper activity is focused in a germinal center-localized subset of CXCR5+ T cells. J Exp Med (2001) 193:1373-81. doi:10.1084/jem.193.12.1373
173. Tonti E, Fedeli M, Napolitano A, Iannacone M, von Andrian UH, Guidotti LG, et al. Follicular helper NKT cells induce limited B cell responses and germinal center formation in the absence of CD4+ T cell help. J Immunol (2012) 188:3217-22. doi:10.4049/jimmunol.1103501
174. Leadbetter EA, Brigl M, Illarionov P, Cohen N, Luteran MC, Pillai S, et al. NK T cells provide lipid antigen-specific cognate help for B cells. Proc Natl Acad Sci U S A (2008) 105:8339-44. doi:10.1073/pnas.0801375105
175. King IL, Amiel E, Tighe M, Mohrs K, Veerapen N, Besra G, et al. The mechanism of splenic invariant NKT cell activation dictates localization in vivo. J Immunol (2013) 191:572-82. doi:10.4049/jimmunol.1300299
176. Barral P, Sánchez-Niño MD, van Rooijen N, Cerundolo V, Batista FD. The location of splenic NKT cells favours their rapid activation by blood-borne antigen. EMBO J (2012) 31:2378-90. doi:10.1038/emboj.2012.87
177. Wong CH, Kubes P. Imaging natural killer T cells in action. Immunol Cell Biol (2013) 91:304-10. doi:10.1038/icb.2013.6
178. Sköld M, Behar SM. Role of CD1d-restricted NKT cells in microbial immunity. Infect Immun (2003) 71:5447-55. doi:10.1128/IAI.71.10.5447
179. Brigl M, Brenner MB. CD1: antigen presentation and T cell function. Annu Rev Immunol (2004) 22:817-90. doi:10.1146/annurev.immunol.22.012703.104608
180. Yu KO, Porcelli SA. The diverse functions of CD1d-restricted NKT cells and their potential for immunotherapy. Immunol Lett (2005) 100:42-55. doi:10.1016/j.imlet.2005.06.010
181. Fischer K, Scotet E, Niemeyer M, Koebernick H, Zerrahn J, Maillet S, et al. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc Natl Acad Sci U S A (2004) 101:10685-90. doi:10.1073/pnas.0403787101
182. Kinjo Y, Wu D, Kim G, Xing GW, Poles MA, Ho DD, et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature (2005) 434:520-5. doi:10.1038/nature03407
183. Sriram V, Du W, Gervay-Hague J, Brutkiewicz RR. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur J Immunol (2005) 35:1692-701. doi:10.1002/eji.200526157
184. Mattner J, Debord KL, Ismail N, Goff RD, Cantu C, Zhou D, et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature (2005) 434:525-9. doi:10.1038/nature03408
185. Kinjo Y, Tupin E, Wu D, Fujio M, Garcia-Navarro R, Benhnia MR, et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol (2006) 7:978-86. doi:10.1038/ni1380
186. Chang Y, Kim HY, Albacker LA, Lee HH, Baumgarth N, Akira S, et al. Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity. J Clin Invest (2011) 121:57-69. doi:10.1172/JCI44845DS1
187. Godfrey DI, Rossjohn J. New ways to turn on NKT cells. J Exp Med (2011) 208:1121-5. doi:10.1084/jem.20110983
188. Amprey JL, Im JS, Turco SJ, Murray HW, Illarionov PA, Besra GS, et al. A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. J Exp Med (2004) 200:895-904. doi:10.1084/jem.20040704
189. Kinjo Y, Illarionov PA, Vela JL, Pei B, Girardi E, Li X, et al. Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nat Immunol (2011) 12:966-74. doi:10.1038/ni.2096
190. Brigl M, Bry L, Kent SC, Gumperz JE, Brenner MB. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol (2003) 4:1230-7. doi:10.1038/ni1002
191. Paget C, Mallevaey T, Speak AO, Torres D, Fontaine J, Sheehan KC, et al. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity (2007) 27:597-609. doi:10.1016/j.immuni.2007.08.017
192. Salio M, Speak AO, Shepherd D, Polzella P, Illarionov PA, Veerapen N, et al. Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation. Proc Natl Acad Sci U S A (2007) 104:20490-5. doi:10.1073/pnas.0710145104
193. Nagarajan NA, Kronenberg M. Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J Immunol (2007) 178:2706-13. doi:10.4049/jimmunol.178.5.2706
194. Wang X, Bishop KA, Hegde S, Rodenkirch LA, Pike JW, Gumperz JE. Human invariant natural killer T cells acquire transient innate responsiveness via histone H4 acetylation induced by weak TCR stimulation. J Exp Med (2012) 209:987-1000. doi:10.1084/jem.20111024
195. a14i NK T cells during MCMV infection. PLoS Pathog (2008) 4:e1000106. doi:10.1371/journal.ppat.1000106
196. Velazquez P, Cameron TO, Kinjo Y, Nagarajan N, Kronenberg M, Dustin ML. Cutting edge: activation by innate cytokines or microbial antigens can cause arrest of natural killer T cell patrolling of liver sinusoids. J Immunol (2008) 180:2024-8. doi:10.4049/jimmunol.180.4.2024
197. Lee WY, Moriarty TJ, Wong CH, Zhou H, Strieter RM, van Rooijen N, et al. An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells. Nat Immunol (2010) 11:295-302. doi:10.1038/ni.1855
198. Tupin E, Benhnia MR, Kinjo Y, Patsey R, Lena CJ, Haller MC, et al. NKT cells prevent chronic joint inflammation after infection with Borrelia burgdorferi. Proc Natl Acad Sci U S A (2008) 105:19863-8. doi:10.1073/pnas.0810519105
199. Lee WY, Sanz MJ, Wong CH, Hardy PO, Salman-Dilgimen A, Moriarty TJ, et al. Invariant natural killer T cells act as an extravascular cytotoxic barrier for joint-invading Lyme Borrelia. Proc Natl Acad Sci U S A (2014) 111:13936-41. doi:10.1073/pnas.1404769111
200. Katchar K, Drouin EE, Steere AC. Natural killer cells and natural killer T cells in Lyme arthritis. Arthritis Res Ther (2013) 15:R183. doi:10.1186/ar4373
201. Hahn DL, Azenabor AA, Beatty WL, Byrne GI. Chlamydia pneumoniae as a respiratory pathogen. Front Biosci (2002) 7:e66-76. doi:10.2741/hahn
202. Rank RG, Yeruva L. Hidden in plain sight: chlamydial gastrointestinal infection and its relevance to persistence in human genital infection. Infect Immun (2014) 82:1362-71. doi:10.1128/IAI.01244-13
203. LaVerda D, Albanese LN, Ruther PE, Morrison SG, Morrison RP, Ault KA, et al. Seroreactivity to Chlamydia trachomatis Hsp10 correlates with severity of human genital tract disease. Infect Immun (2000) 68:303-9. doi:10.1128/IAI.68.1.303-309.2000
204. Zhang X, Pacheco-Tena C, Inman RD. Microbe hunting in the joints. Arthritis Rheum (2003) 49:479-82. doi:10.1002/art.11186
205. Bharhani MS, Chiu B, Na KS, Inman RD. Activation of invariant NKT cells confers protection against Chlamydia trachomatis-induced arthritis. Int Immunol (2009) 21:859-70. doi:10.1093/intimm/dxp052
206. Yang X. Natural killer T (NKT) cell subsets in chlamydial infections. Adv Exp Med Biol (2007) 601:243-6. doi:10.1007/978-0-387-72005-0_25
207. Wang H, Zhao L, Peng Y, Liu J, Qi M, Chen Q, et al. Protective role of α-galactosylceramide-stimulated natural killer T cells in genital tract infection with Chlamydia muridarum. FEMS Immunol Med Microbiol (2012) 65:43-54. doi:10.1111/j.1574-695X.2012.00939.x
208. Jiang J, Karimi O, Ouburg S, Champion CI, Khurana A, Liu G, et al. Interruption of CXCL13-CXCR5 axis increases upper genital tract pathology and activation of NKT cells following chlamydial genital infection. PLoS One (2012) 7:e47487. doi:10.1371/journal.pone.0047487
209. + natural killer T cell-mediated host defense against Streptococcus pneumoniae infection in murine lungs. Microbes Infect (2007) 9:364-74. doi:10.1016/j.micinf.2006.12.003
210. Holzapfel KL, Tyznik AJ, Kronenberg M, Hogquist KA. Antigen-dependent versus-independent activation of invariant NKT cells during infection. J Immunol (2014) 192:5490-8. doi:10.4049/jimmunol.1400722
211. Moran AE, Holzapfel KL, Xing Y, Cunningham NR, Maltzman JS, Punt J, et al. T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J Exp Med (2011) 208:1279-89. doi:10.1084/jem.20110308
212. a14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection. J Immunol (2001) 167:6525-32. doi:10.4049/jimmunol.167.11.6525
213. Bai L, Deng S, Reboulet R, Mathew R, Teyton L, Savage PB, et al. Natural killer T (NKT)-B-cell interactions promote prolonged antibody responses and long-term memory to pneumococcal capsular polysaccharides. Proc Natl Acad Sci U S A (2013) 110:16097-102. doi:10.1073/pnas.1303218110
214. Herzig DS, Driver BR, Fang G, Toliver-Kinsky TE, Shute EN, Sherwood ER. Regulation of lymphocyte trafficking by CXC chemokine receptor 3 during septic shock. Am J Respir Crit Care Med (2012) 185:291-300. doi:10.1164/rccm.201108-1560OC
215. Fusakio ME, Mohammed JP, Laumonnier Y, Hoebe K, Köhl J, Mattner J. C5a regulates NKT and NK cell functions in sepsis. J Immunol (2011) 187:5805-12. doi:10.4049/jimmunol.1100338
216. Chackerian A, Alt J, Perera V, Behar SM. Activation of NKT cells protects mice from tuberculosis. Infect Immun (2002) 70:6302-9. doi:10.1128/IAI.70.11.6302-6309.2002
217. Sada-Ovalle I, Chiba A, Gonzales A, Brenner MB, Behar SM. Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-γ, and kill intracellular bacteria. PLoS Pathog (2008) 4:e1000239. doi:10.1371/journal.ppat.1000239
218. Lee LN, Ronan EO, de Lara C, Franken KL, Ottenhoff TH, Tchilian EZ, et al. CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis. Infect Immun (2011) 79:3328-37. doi:10.1128/IAI.01133-10
219. Mempel M, Ronet C, Suarez F, Gilleron M, Puzo G, Van Kaer L, et al. Natural killer T cells restricted by the monomorphic MHC class 1b CD1d1 molecules behave like inflammatory cells. J Immunol (2002) 168:365-71. doi:10.4049/jimmunol.168.1.365
220. Stolberg VR, Chiu B, Martin BE, Shah SA, Sandor M, Chensue SW. Cysteine-cysteinyl chemokine receptor 6 mediates invariant natural killer T cell airway recruitment and innate stage resistance during mycobacterial infection. J Innate Immun (2011) 3:99-108. doi:10.1159/000321156
221. Jiang X, Zhang M, Lai Q, Huang X, Li Y, Sun J, et al. Restored circulating invariant NKT cells are associated with viral control in patients with chronic hepatitis B. PLoS One (2011) 6:e28871. doi:10.1371/journal.pone.0028871
222. Hadziyannis SJ, Vassilopoulos D, Hadziyannis E. The natural course of chronic hepatitis B virus infection and its management. Adv Pharmacol (2013) 67:247-91. doi:10.1016/B978-0-12-405880-4.00007-X
223. Tripathy AS, Das R, Chadha MS, Arankalle VA. Epidemic of hepatitis B with high mortality in India: association of fulminant disease with lack of CCL4 and natural killer T cells. J Viral Hepat (2011) 18:e415-22. doi:10.1111/j.1365-2893.2011.01457.x
224. Li J, Han Y, Jin K, Wan Y, Wang S, Liu B, et al. Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and natural killer T (NKT) cells in patients with acute hepatitis B infection. Virol J (2011) 8:1-8. doi:10.1186/1743-422X-8-199
225. Inoue M, Kanto T, Miyatake H, Itose I, Miyazaki M, Yakushijin T, et al. Enhanced ability of peripheral invariant natural killer T cells to produce IL-13 in chronic hepatitis C virus infection. J Hepatol (2006) 45:190-6. doi:10.1016/j.jhep.2006.01.034
226. Apolinario A, Majano PL, Alvarez-Perez E, Saez A, Lozano C, Vargas J, et al. Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease. Am J Gastroenterol (2002) 97:2861-70. doi:10.1111/j.1572-0241.2002.07054.x
227. Harvey CE, Post JJ, Palladinetti P, Freeman AJ, Ffrench RA, Kumar RK, et al. Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation. J Leukoc Biol (2003) 74:360-9. doi:10.1189/jlb.0303093
228. De Lalla C, Galli G, Aldrighetti L, Romeo R, Mariani M, Monno A, et al. Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis. J Immunol (2004) 173:1417-25. doi:10.4049/jimmunol.173.2.1417
229. Matangkasombut P, Chan-In W, Opasawaschai A, Pongchaikul P, Tangthawornchaikul N, Vasanawathana S, et al. Invariant NKT cell response to dengue virus infection in human. PLoS Negl Trop Dis (2014) 8:e2955. doi:10.1371/journal.pntd.0002955
230. Renneson J, Guabiraba R, Maillet I, Marques RE, Ivanov S, Fontaine J, et al. A detrimental role for invariant natural killer T cells in the pathogenesis of experimental dengue virus infection. Am J Pathol (2011) 179:1872-83. doi:10.1016/j.ajpath.2011.06.023
231. St John AL, Rathore AP, Yap H, Ng ML, Metcalfe DD, Vasudevan SG, et al. Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance. Proc Natl Acad Sci U S A (2011) 108:9190-5. doi:10.1073/pnas.1105079108
232. Chen WW, Xie YX, Zhang YH, Feng YQ, Li BA, Li B, et al. [Changes and analysis of peripheral white blood cells and lymphocyte subsets for patients with pandemic influenza A virus (H1N1) infection]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi (2010) 24:331-3.
233. Kok WL, Denney L, Benam K, Cole S, Clelland C, McMichael AJ, et al. Pivotal advance: invariant NKT cells reduce accumulation of inflammatory monocytes in the lungs and decrease immune-pathology during severe influenza A virus infection. J Leukoc Biol (2012) 91:357-68. doi:10.1189/jlb.0411184
234. 2 pneumonia. J Immunol (2011) 186:5590-602. doi:10.4049/jimmunol.1002348
235. Ishikawa H, Tanaka K, Kutsukake E, Fukui T, Sasaki H, Hata A, et al. IFN-α production downstream of NKT cell activation in mice infected with influenza virus enhances the cytolytic activities of both NK cells and viral antigen-specific CD8+ T cells. Virology (2010) 407:325-32. doi:10.1016/j.virol.2010.08.030
236. De Santo C, Salio M, Masri SH, Lee LY, Dong T, Speak AO, et al. Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J Clin Invest (2008) 118:4036-48. doi:10.1172/JCI36264
237. Gebremeskel S, Clattenburg DR, Slauenwhite D, Lobert L, Johnston B. Natural killer T cell activation overcomes immunosuppression to enhance clearance of post-surgical breast cancer metastasis in mice. Oncoimmunology (2015) 4:e995562. doi:10.1080/2162402X.2014.995562
238. Ko SY, Ko HJ, Chang WS, Park SH, Kweon MN, Kang CY. α-galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor. J Immunol (2005) 175:3309-17. doi:10.4049/jimmunol.175.5.3309
239. Youn HJ, Ko SY, Lee KA, Ko HJ, Lee YS, Fujihashi K, et al. A single intranasal immunization with inactivated influenza virus and α-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system. Vaccine (2007) 25:5189-98. doi:10.1016/j.vaccine.2007.04.081
240. Guillonneau C, Mintern JD, Hubert FX, Hurt AC, Besra GS, Porcelli S, et al. Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity. Proc Natl Acad Sci U S A (2009) 106:3330-5. doi:10.1073/pnas.0813309106
241. Kopecky-Bromberg SA, Fraser KA, Pica N, Carnero E, Moran TM, Franck RW, et al. α-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine. Vaccine (2009) 27:3766-74. doi:10.1016/j.vaccine.2009.03.090
242. Kamijuku H, Nagata Y, Jiang X, Ichinohe T, Tashiro T, Mori K, et al. Mechanism of NKT cell activation by intranasal coadministration of α-galactosylceramide, which can induce cross-protection against influenza viruses. Mucosal Immunol (2008) 1:208-18. doi:10.1038/mi.2008.2
243. Motsinger A, Haas DW, Stanic AK, Van Kaer L, Joyce S, Unutmaz D. CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection. J Exp Med (2002) 195:869-79. doi:10.1084/jem.20011712
244. Fleuridor R, Wilson B, Hou R, Landay A, Kessler H, Al-Harthi L. CD1d-restricted natural killer T cells are potent targets for human immunodeficiency virus infection. Immunology (2003) 108:3-9. doi:10.1046/j.1365-2567.2003.01560.x
245. Liao F, Alkhatib G, Peden KW, Sharma G, Berger EA, Farber JM. STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J Exp Med (1997) 185:2015-23. doi:10.1084/jem.185.11.2015
246. Deng HK, Unutmaz D, KewalRamani VN, Littman DR. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature (1997) 388:296-300. doi:10.1038/40894
247. Loetscher M, Amara A, Oberlin E, Brass N, Legler D, Loetscher P, et al. TYMSTR, a putative chemokine receptor selectively expressed in activated T cells, exhibits HIV-1 coreceptor function. Curr Biol (1997) 7:652-60. doi:10.1016/S0960-9822(06)00292-2
248. a24 natural killer T cells in human immunodeficiency virus infection. J Virol (2002) 76:7528-34. doi:10.1128/JVI.76.15.7528
249. Van der Vliet HJ, von Blomberg BM, Hazenberg MD, Nishi N, Otto SA, van Benthem BH, et al. Selective decrease in circulating Vα24+Vβ11+ NKT cells during HIV type 1 infection. J Immunol (2002) 168:1490-5. doi:10.4049/jimmunol.168.3.1490
250. Fernandez CS, Kelleher AD, Finlayson R, Godfrey DI, Kent SJ. NKT cell depletion in humans during early HIV infection. Immunol Cell Biol (2014) 92:578-90. doi:10.1038/icb.2014.25
251. Parasa VR, Selvaraj A, Sikhamani R, Raja A. Interleukins 15 and 12 in combination expand the selective loss of natural killer T cells in HIV infection in vitro. Clin Exp Med (2014) 1:3-11. doi:10.1007/s10238-014-0278-5
252. Van der Vliet HJ, van Vonderen MG, Molling JW, Bontkes HJ, Reijm M, Reiss P, et al. Cutting edge: rapid recovery of NKT cells upon institution of highly active antiretroviral therapy for HIV-1 infection. J Immunol (2006) 177:5775-8. doi:10.4049/jimmunol.177.9.5775
253. Pakker NG, Notermans DW, de Boer RJ, Roos MT, de Wolf F, Hill A, et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med (1998) 4:208-14. doi:10.1038/nm0298-208
254. Bucy RP, Hockett RD, Derdeyn CA, Saag MS, Squires K, Sillers M, et al. Initial increase in blood CD4+ lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. J Clin Invest (1999) 103:1391-8. doi:10.1172/JCI5863
255. Moll M, Kuylenstierna C, Gonzalez VD, Andersson SK, Bosnjak L, Sönnerborg A, et al. Severe functional impairment and elevated PD-1 expression in CD1d-restricted NKT cells retained during chronic HIV-1 infection. Eur J Immunol (2009) 39:902-11. doi:10.1002/eji.200838780
256. Snyder-Cappione JE, Loo CP, Carvalho KI, Kuylenstierna C, Deeks SG, Hecht FM, et al. Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expression. AIDS (2009) 23:1965-70. doi:10.1097/QAD.0b013e32832b5134
257. Huang Y, Chen A, Li X, Chen Z, Zhang W, Song Y, et al. Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, α-galactosylceramide. Vaccine (2008) 26:1807-16. doi:10.1016/j.vaccine.2008.02.002
258. Courtney AN, Nehete PN, Nehete BP, Thapa P, Zhou D, Sastry KJ. α-galactosylceramide is an effective mucosal adjuvant for repeated intranasal or oral delivery of HIV peptide antigens. Vaccine (2009) 27:3335-41. doi:10.1016/j.vaccine.2009.01.083
259. Moll M, Snyder-cappione J, Spotts G, Hecht FM, Sandberg JK, Nixon DF. Expansion of CD1d-restricted NKT cells in patients with primary HIV-1 infection treated with interleukin-2. Blood (2006) 107:3081-4. doi:10.1182/blood-2005-09-3636
260. Snyder-Cappione JE, Nixon DF, Loo CP, Chapman JM, Meiklejohn DA, Melo FF, et al. Individuals with pulmonary tuberculosis have lower levels of circulating CD1d-restricted NKT cells. J Infect Dis (2007) 195:1361-4. doi:10.1086/513567
261. Kee SJ, Kwon YS, Park YW, Cho YN, Lee SJ, Kim TJ, et al. Dysfunction of natural killer T cells in patients with active Mycobacterium tuberculosis infection. Infect Immun (2012) 80:2100-8. doi:10.1128/IAI.06018-11
262. Bricard G, Cesson V, Devevre E, Bouzourene H, Barbey C, Rufer N, et al. Enrichment of human CD4+ Vα24/Vβ11 invariant NKT cells in intrahepatic malignant tumors. J Immunol (2009) 182:5140-51. doi:10.4049/jimmunol.0711086
263. a24-positive natural killer T cells: a prognostic factor for primary colorectal carcinomas. Clin Cancer Res (2005) 11:7322-7. doi:10.1158/1078-0432.CCR-05-0877
264. Metelitsa LS, Wu HW, Wang H, Yang Y, Warsi Z, Asgharzadeh S, et al. Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2. J Exp Med (2004) 199:1213-21. doi:10.1084/jem.20031462
265. Chan AC, Neeson P, Leeansyah E, Tainton K, Quach H, Prince HM, et al. Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patients. Leukemia (2010) 24:592-600. doi:10.1038/leu.2009.279
266. Chan AC, Neeson P, Leeansyah E, Tainton K, Quach H, Prince HM, et al. Natural killer T cell defects in multiple myeloma and the impact of lenalidomide therapy. Clin Exp Immunol (2014) 175:49-58. doi:10.1111/cei.12196
267. a14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity. J Exp Med (2003) 198:1785-96. doi:10.1084/jem.20021562
268. Pobezinsky LA, Etzensperger R, Jeurling S, Alag A, Kadakia T, McCaughtry TM, et al. Let-7 microRNAs target the lineage-specific transcription factor PLZF to regulate terminal NKT cell differentiation and effector function. Nat Immunol (2015) 16:517-24. doi:10.1038/ni.3146